Jamjoom Pharma Q1 Profit Jumps 52.5% to SAR 157 Mln

Jamjoom Pharmaceuticals Factory Co. reported on Wednesday a 52.5% year-on-year rise in first-quarter net profit to SAR 157 million, up from SAR 102.9 million in the same quarter last year. This came after the announcement of the initial financial results for the three-month period ending March 31, 2025.

Operational profit reached SAR 158.2 million in the first quarter, up 24.2% from SAR 127.2 million in the prior-year period.

Shareholders’ equity (excluding non-controlling interests) in the three-month period stood at SAR 1.54 billion, compared to SAR 1.46 billion a year earlier, marking a 5.8% increase.

Profits per share in the current period rose to SAR 2.24 from SAR 1.47 in the same period last year.